SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-026931
Filing Date
2021-02-23
Accepted
2021-02-23 18:49:51
Documents
2
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm217706-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm217706-6_4seq1.xml 4 6343
2 EXHIBIT 24 tm217706d6_ex24.htm EX-24 7540
  Complete submission text file 0001104659-21-026931.txt   15362
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Khattar Jack A. (Reporting) CIK: 0001539937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 21667532